Where is the scope of blister packaging in the USA for the year 2022-2027?

The United States Blister Packaging Market is estimated to grow at a CAGR of 5.6 per cent between 2022 and 2026. The COVID-19 outbreak, global expansion of regulatory standards, population health management, inventions, more knowledgeable customers, and a surge in OTC pharmaceuticals have all shown a potential accelerated packaging growth. So, it’s important to know the particular points in detail:

Potential Market trends

The Pharmaceutical Industry

1. Premium Insulation: The pharmaceutical industry places unique demands on this kind of packaging solution as it provides good quality insulation from the external environment, is cost-effective, has high levels of protection, is highly convenient at handling, and keeps the medicine's effectiveness. These packs are ideally suited to comply with severe rules and are widely recognized for their protective features, cost-effectiveness, adaptability, and compliance with pharmaceutical and packaging industry standards.
2. Track of Intake: Adherence is improved when pharmaceutical subjects are blister packaged because customers can keep track of their pills and dosage. Blisters' unit dosage feature minimizes the possibility of erroneous dosing.
3. Transparent distribution: Pharmaceutical technologists and pharmacists are concerned about the production of prescription drugs at the retail level. When drugs are administered in an open environment such as a supermarket or drug shop, they may be harmed when they are passed from container to container. This kind of packaging enables direct distribution to the customer.
4. Integrity: While maintaining product integrity remains the fundamental objective of pharmaceutical packaging, efforts to reduce packaging costs continue to be made in all sectors of the packaging business.

In shorts

Additionally, pharmaceutical businesses that serve the solid dose segment are expanding their manufacturing facilities in the United States. For instance, Aphena Pharma Solutions announced in September 2020 the establishment of a solid dosage business in Cookeville, Tennessee. According to the corporation, the facility will have 24 high-speed bottling lines and eight thermoform blister packaging machines. This illustrates the high need for blister packages in the region.

How the US is directly responsible for the growth?

1. Hub for ailments: Because the country is prone to numerous ailments, various CDMOs and CMOs have developed a presence in the United States to introduce new APIs for Solid Drugs that aid in the treatment of various diseases. This is likely to fuel growth this industry in the country. For example, the Centers for Disease Control and Prevention reports that new cases of tuberculosis have been reported in conjunction with the rapid spread of COVID-19. Alaska and Huwai respectively had 7.5 and 6.5 per cent of incidents per 100,000 population.
2. Populated country: Additionally, as the country's population grows and diseases spread, pharmaceutical companies have expanded manufacturing facilities for solid doses, driving up the need for blister packing in the country. For example, in September 2020, Aphena Pharma Solutions announced a USD 21 million investment in Cookeville, Tennessee, to grow the Solid dosage division. This significantly boosts the country's packaging needs.

How good is the competition?

The market in the United States is moderately fragmented. Partnerships, mergers, and acquisitions have been a significant strategy for vendors in the market to produce products that are acceptable in the end-user industry, where packaging materials are subjected to stringent quality tests to ensure they do not contaminate the contents or harm health. Maintaining a steady flow of raw materials continues to be a challenge that necessitates collaboration. Amcor Ltd, Westrock Company, Sonoco Products Company, Constantia Flexibles GmbH, and Honeywell International Inc. are among the market's key participants.